logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
17/06/2025
Lai: The monthly cost of all approved Telbivudine doses is $499 or lower.
Latest
13 m ago
The Bank of Montreal in Canada: lowered the rating of Sarepta Therapeutics (SRPT.US) from outperform to market perform, and adjusted the target price from $120.00 to $70.00.
13 m ago
Western Petroleum Company: It is expected that oil prices will fall back to the levels before the latest round of conflict between Israel and Iran.
13 m ago
Western Oil Company: It is expected that the price of crude oil will fall back to the level before the latest conflict between Israel and Iran erupted.
14 m ago
B. Riley Securities: Upgrade Hudson Technologies (HDSN.US) from Neutral to Buy rating, with a target price increased from $7.50 to $9.00.
16 m ago
B. Riley Securities: Maintains Buy rating on MediciNova (MNOV.US), adjusted from Buy rating with target price adjusted from $6.00 to $5.00.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.